The Neurodegeneration Cure Curve

What if the cure for neurodegeneration didn't just change the brain-but changed the rules governing it?When ten-year-old Sofía Vega attends a free brain-health screening, an experimental AI detects something no one expected. NeuroSeed, the biotech company behind the programme, offers her father an extraordinary opportunity: an experimental therapy designed to identify neurodegeneration decades early and alter its course before the disease can take hold.For Dr Lena Harrow, the scientist who helped build NeuroSeed's technology, Sofía should represent everything the company promised to achieve.Instead, she becomes the first sign that something is dangerously wrong.As Sofía's abilities begin to change, Lena uncovers suppressed trial data, manipulated risk models and troubling patterns among patients the system was designed to protect. With regulatory specialist Maya Reddick digging into the same evidence, the two women discover that NeuroSeed's celebrated breakthrough may be producing effects far beyond its intended biology.And the deeper they investigate, the less certain it becomes that what is emerging can still be contained inside a laboratory.Caught between a father desperate to protect his daughter, a company determined to control its discovery and a phenomenon that appears to be learning from the people around it, Lena must decide where medicine ends-and something entirely new begins.The Neurodegeneration Cure Curve is a speculative biotech thriller about medical ambition, artificial intelligence, scientific responsibility and the dangerous distance between curing a human being and redesigning one.